PIRT Inhibitors encompass a wide array of compounds that exert their inhibitory effects indirectly through various ion channels and associated cellular processes. As PIRT is mainly known for its interaction with TRPV1 ion channels, multiple TRPV1 antagonists like Capsazepine and AMG9810 are included in this list. These inhibitors not only block TRPV1 channels but also prevent PIRT from effectively acting as a modulator. Furthermore, mechanistically activated ion channels, inhibited by GsMTx-4, and sodium channels, blocked by Tetrodotoxin, also contribute to the complex functionality of PIRT. Therefore, these inhibitors affect PIRT's role in ion channel regulation and its involvement in cellular signaling mechanisms.
The chemical class of PIRT inhibitors is distinguished by their targeted interference in ion channel regulation. While some inhibitors, such as Ruthenium Red, are broad in their spectrum and inhibit various TRP channels, others like Pyr3 and YM-58483 are more specialized, targeting TRPC3 and Orai1 channels respectively. Specific inhibitors for TRPA1, like PF-4840154 and HC-030031, can directly affect PIRT's role in pain perception pathways through this particular ion channel. All these compounds play pivotal roles in manipulating cellular processes like calcium influx, mechanical sensitivity, and cellular excitability, which are aspects modulated by PIRT. This shows how nuanced and specialized the chemical class of PIRT inhibitors can be in targeting the regulation and functionality of this protein.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Capsazepine | 138977-28-3 | sc-201098 sc-201098A | 5 mg 25 mg | $148.00 $459.00 | 11 | |
Vanilloid receptor antagonist that inhibits TRPV1, thereby modulating PIRT’s role in TRPV1-dependent ion channel regulation. | ||||||
AMG-9810 | 545395-94-6 | sc-201477 sc-201477A | 10 mg 50 mg | $86.00 $344.00 | 3 | |
TRPV1 antagonist, interferes with PIRT's ability to modulate TRPV1 activity, affecting calcium influx and downstream signaling. | ||||||
Ruthenium red | 11103-72-3 | sc-202328 sc-202328A | 500 mg 1 g | $188.00 $250.00 | 13 | |
Blocks various calcium channels including TRPV, affecting PIRT's role in calcium ion regulation. | ||||||
HC-030031 | 349085-38-7 | sc-203994 sc-203994A | 10 mg 50 mg | $89.00 $333.00 | 2 | |
Inhibits TRPA1 ion channel, thus affecting PIRT's role in pain perception through TRPA1. | ||||||
SK&F 96365 | 130495-35-1 | sc-201475 sc-201475B sc-201475A sc-201475C | 5 mg 10 mg 25 mg 50 mg | $103.00 $158.00 $397.00 $656.00 | 2 | |
Non-selective TRP channel blocker, can inhibit multiple TRP channels that PIRT may regulate. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
Broad-spectrum TRP channel inhibitor that interferes with ion channels regulated by PIRT. | ||||||
Pyr3 | 1160514-60-2 | sc-301624 sc-301624A sc-301624B | 5 mg 10 mg 25 mg | $151.00 $260.00 $520.00 | ||
TRPC3 ion channel blocker, can affect PIRT’s role in modulating TRPC3 activity. | ||||||
CRAC Channel Inhibitor, BTP2 | 223499-30-7 | sc-221441 | 5 mg | $189.00 | 9 | |
Blocks Orai1 calcium channels that could intersect with PIRT-mediated regulation in calcium signaling. | ||||||